Effects of EPA and vitamin E on serum enzymatic antioxidants and peroxidation indices in patients with type II diabetes mellitus

Iranian Journal of Public Health

Volumn 39, Issue 3, 2010, Pages 82-91

  Sarbolouki, S H ^a   Djalali, M ^a   Dorosty, A R ^a   Djazayery, S A ^a   Eshraghian, M R ^a   Ebadi, S A R ^b   Hashemi, S B ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Diabetes mellitus; Eicosapentaenoic acid; EPA; Total antioxidant capacity; Vitamin E

Indexed keywords

EID: 77958528528     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ramel A, Martinéz A, Kiely M, Morais G, Bandarra NM,Thorsdottir I (2008). Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia, 51: 1261-1268.
2. Matsuzawa Y, Funahashi T, Nakamura T (1999). Molecular mechanism of metabolic syndrome X: contribution of adipocyte-derived bioactive substance. Ann NY Acad Sci, 892: 146-154.
3. Pérez-Matute P, Pérez-Echarri N, Martínez JA, Marti A, Moreno-Aliaga MJ (2007). Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: Rrole of apoptosis, adiponectin and tumour necrosis factor-α. British Journal of Nutrition, 97: 389-398.
4. Ramel A, Jonsdottir MT, Thorsdottir I (2009). Consumption of cod and weight loss in young overweight and obese adults on an energy reduced diet for 8-weeks. Nutrition, Metabolism and Cardiovascular Diseases, In Press, Corrected Proof.
5. Takahashi YTI (2000). Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. British Journal of Nutrition, 84: 175-184.
6. Barre DE (2007). The Role of Consumption of Alpha-Linolenic, Eicosapentaenoic and Docosahexaenoic Acids in Human Metabolic Syndrome and Type 2 Diabetes. Journal of Oleo Science, 56: 319-325.
7. Aas V, Rokling-Andersen, Merethe H, Tran-heim KE, Thoresen G, Hege R, Arild C (2006). Eicosapentaenoic acid (20: 5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells. J Lipid Res, 47: 366-374.
8. Yolanda BL, Adriana G, Chicco (2006). Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. Journal of Nutritional Biochemistry, 17: 1-13.
9. Hamazaki TO (2001). Fatty Acids and Lipids- New Findings, World Review of Nutrition and Dietetics World Review of Nutrition and Dietetics, Us: 28-30.
10. BarÓ L, FonollÁ J, PeñA JL, MartÍNez-FéRez A, Lucena A, JimÉNez J, Boza JJ, LÓPez-Huertas E (2003). n -3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of en-dothelial adhesion molecules in healthy humans. Clinical Nutrition, 22: 175-182.
11. Higgins S, Carroll YL, McCarthy SN, Corridan BM, Roche HM, Wallace JMW, O'Brien NM, Morrissey PA (2001). Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids. British Journal of Nutrition, 85: 23-31.
12. Colquhoun A, Schumacher RI (2001). Gama-Linolenic acid and eicosapentaenoic acid induce medications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinosarcoma cells. Biochimica et Biophysica Acta, 1153: 207-219
13. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T (2008). Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol, 42: 413-418.
14. Kikuyawa K (2001). Effect of W6 and W3 fatty acid supplementation on rat tissue lipid peroxidation World Rev Nutr Diet, 88: 28-34.
15. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ (2002). Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr, 76: 1007-1015.
16. Mahan LK, Escott-Stump S (2008). Krause's Food & Nutrition Therapy. Saunders Inc, Philadelphia, 12, pp.: 800-802.
17. Wilkinson IB, Waring WS, Cockcroft JR (2003). Hypertention. Churchill Livingstone Inc, London, p: 50.
18. Erel O (2004). A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry, 37: 277-285.
19. Paglia DE, Valentine WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 70: 158-169.
20. Sun Y, Oberley LW, Li Y (1988). A simple method for clinical assay of superoxide dismutase. Clin Chem, 34: 497-500.
21. Aebi H (1984). Catalase in vitro. Methods in Enzymology, 105: 121-126.
22. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A (1992). Malondialde-hyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem, 38: 704-709.
23. Castegna A, Drake J, Pocernich C, Butterfield DA (2003). Protein Carbonyl Levels-An Assessment of Protein Oxidation. Methods in Biological Oxidative Stress, pp.: 161-168.
24. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ (1999). Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr, 70: 817-825.
25. Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG (1997). The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study. Diabetes Care, 20: 913-921.
26. Trevor A (2003). Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free radical biology and medicine, 7: 772-81.
27. Trevor A, Mori L, Beilin J (2001). Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Current Opinion in Lipidology, 12: 11-17.
28. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ (2000). Purified eicosapentaenoic and docosahex-aenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr, 71: 1085-1094.
29. Brude IR, Drevon CA, Hjermann I, Seljeflot I, Lund-Katz S, Saarem K (1997). Peroxi-dation of LDL From Combined-Hyperlipi-demic Male Smokers Supplied With n-3 Fatty Acids and Antioxidants. Arterioscler Thromb Vasc Biol, 17: 2576-2588.
30. Ramirez-Tortosa C, Lopez-Pedrosa JM, Suarez A, Ros E, Mataix J, Gil A (1999). Olive oil and fish oil enriched diets modify plasma lipids and susceptibility of LDL to oxida-tive modification in free-living male patients with peripheral vascular disease: the Spanish Nutrition Study. British Journal of Nutrition, 82: 31-39.
31. Carpentier Y, Von A, Protois L, Malaisse WJ (2006). n-3 Fatty acids and the metabolic syndrome. Am J Clin Nutr, 83: S1499-S1504.
32. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterol-aemic patients (JELIS): a randomised open-label, blinded endpoint analysis. The Lancet, 369: 1090-1098.
33. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y et al. (2003). Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. Journal of Hepatology, 38: 32-38.
34. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H et al. (2000). Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. Journal of Hepatology, 33: 616-622.